

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.43247318 |
| 2 | vocalization behavior (GO:0071625) | 5.19681387 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.10222104 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.10222104 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.10222104 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.10222104 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.10222104 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.10222104 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.07965776 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.05629688 |
| 11 | neurotransmitter catabolic process (GO:0042135) | 4.90101412 |
| 12 | detection of other organism (GO:0098543) | 4.70625441 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.69976926 |
| 14 | microglial cell activation (GO:0001774) | 4.61762338 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.61679469 |
| 16 | granulocyte activation (GO:0036230) | 4.58914597 |
| 17 | response to peptidoglycan (GO:0032494) | 4.54582692 |
| 18 | neuron recognition (GO:0008038) | 4.53693237 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.40096200 |
| 20 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.38655575 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 4.35577300 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.34225691 |
| 23 | detection of bacterium (GO:0016045) | 4.32951014 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.32801702 |
| 25 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.31959719 |
| 26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.24665741 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.24080667 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.23060672 |
| 29 | detection of external biotic stimulus (GO:0098581) | 4.20978527 |
| 30 | respiratory burst (GO:0045730) | 4.12364827 |
| 31 | neutrophil activation (GO:0042119) | 4.10778171 |
| 32 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.08322687 |
| 33 | neurotransmitter biosynthetic process (GO:0042136) | 4.07150876 |
| 34 | proline transport (GO:0015824) | 4.06083679 |
| 35 | protein localization to synapse (GO:0035418) | 4.02682213 |
| 36 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.98238526 |
| 37 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.98213515 |
| 38 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.98213515 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.98087747 |
| 40 | presynaptic membrane organization (GO:0097090) | 3.97062805 |
| 41 | mating behavior (GO:0007617) | 3.95001513 |
| 42 | cellular extravasation (GO:0045123) | 3.93329922 |
| 43 | ATP synthesis coupled proton transport (GO:0015986) | 3.92644576 |
| 44 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.92644576 |
| 45 | glutamate secretion (GO:0014047) | 3.89405285 |
| 46 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.88257304 |
| 47 | detection of biotic stimulus (GO:0009595) | 3.86711280 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.86673799 |
| 49 | neurotransmitter transport (GO:0006836) | 3.85701422 |
| 50 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.84419656 |
| 51 | regulation of helicase activity (GO:0051095) | 3.84224440 |
| 52 | succinate metabolic process (GO:0006105) | 3.84151364 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.84010546 |
| 54 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.81384499 |
| 55 | oxygen transport (GO:0015671) | 3.81326840 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.80576164 |
| 57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76092390 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.75470860 |
| 59 | B cell mediated immunity (GO:0019724) | 3.75296579 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.74421514 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.73514304 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 3.71527433 |
| 63 | histone H3-K9 demethylation (GO:0033169) | 3.70498168 |
| 64 | axonal fasciculation (GO:0007413) | 3.64516773 |
| 65 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.62730556 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.62463600 |
| 67 | neurotransmitter metabolic process (GO:0042133) | 3.62024714 |
| 68 | dopamine biosynthetic process (GO:0042416) | 3.61769599 |
| 69 | positive regulation of synapse assembly (GO:0051965) | 3.61490298 |
| 70 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.59709726 |
| 71 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.58943293 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 3.58943293 |
| 73 | catecholamine transport (GO:0051937) | 3.58115468 |
| 74 | layer formation in cerebral cortex (GO:0021819) | 3.55256269 |
| 75 | negative regulation of cell killing (GO:0031342) | 3.54330720 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54330720 |
| 77 | synaptic transmission, glutamatergic (GO:0035249) | 3.53886445 |
| 78 | neutrophil mediated immunity (GO:0002446) | 3.53296360 |
| 79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.52483920 |
| 80 | myeloid leukocyte mediated immunity (GO:0002444) | 3.52071338 |
| 81 | synaptic vesicle maturation (GO:0016188) | 3.51296806 |
| 82 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.51062895 |
| 83 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.49253674 |
| 84 | presynaptic membrane assembly (GO:0097105) | 3.47800874 |
| 85 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.44916976 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.44800873 |
| 87 | macrophage activation (GO:0042116) | 3.43817177 |
| 88 | oligosaccharide catabolic process (GO:0009313) | 3.40342692 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.38626117 |
| 90 | response to host immune response (GO:0052572) | 3.38626117 |
| 91 | transferrin transport (GO:0033572) | 3.36460673 |
| 92 | regulation of protein kinase A signaling (GO:0010738) | 3.35995906 |
| 93 | regulation of macrophage chemotaxis (GO:0010758) | 3.33853234 |
| 94 | response to histamine (GO:0034776) | 3.32909856 |
| 95 | respiratory electron transport chain (GO:0022904) | 3.32747825 |
| 96 | dopamine transport (GO:0015872) | 3.30334694 |
| 97 | natural killer cell differentiation (GO:0001779) | 3.29954328 |
| 98 | exploration behavior (GO:0035640) | 3.28545350 |
| 99 | electron transport chain (GO:0022900) | 3.27078511 |
| 100 | synaptic transmission, dopaminergic (GO:0001963) | 3.26768869 |
| 101 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25976367 |
| 102 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.25805728 |
| 103 | locomotory exploration behavior (GO:0035641) | 3.23602861 |
| 104 | catecholamine biosynthetic process (GO:0042423) | 3.23166235 |
| 105 | catechol-containing compound biosynthetic process (GO:0009713) | 3.23166235 |
| 106 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22774977 |
| 107 | synaptic transmission, cholinergic (GO:0007271) | 3.22379328 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 3.21450855 |
| 109 | trivalent inorganic cation transport (GO:0072512) | 3.16462376 |
| 110 | ferric iron transport (GO:0015682) | 3.16462376 |
| 111 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.14565695 |
| 112 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.14457478 |
| 113 | cellular response to ammonium ion (GO:0071242) | 3.14308352 |
| 114 | superoxide anion generation (GO:0042554) | 3.09715747 |
| 115 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08898513 |
| 116 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07648914 |
| 117 | dendrite development (GO:0016358) | 3.05220859 |
| 118 | regulation of synapse structural plasticity (GO:0051823) | 3.04626842 |
| 119 | regulation of synaptic vesicle transport (GO:1902803) | 3.03552388 |
| 120 | startle response (GO:0001964) | 3.02843694 |
| 121 | regulation of postsynaptic membrane potential (GO:0060078) | 3.01811911 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 3.00846838 |
| 123 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.99435328 |
| 124 | regulation of mast cell activation (GO:0033003) | 2.98515774 |
| 125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95124628 |
| 126 | neuromuscular process controlling posture (GO:0050884) | 2.94860164 |
| 127 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.94845208 |
| 128 | phagocytosis, engulfment (GO:0006911) | 2.94652799 |
| 129 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.94055781 |
| 130 | regulation of glutamate secretion (GO:0014048) | 2.94051255 |
| 131 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.93291965 |
| 132 | imidazole-containing compound metabolic process (GO:0052803) | 2.92939338 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.92439148 |
| 134 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92156688 |
| 135 | dendritic spine morphogenesis (GO:0060997) | 2.91780031 |
| 136 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91514475 |
| 137 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91417491 |
| 138 | leukocyte degranulation (GO:0043299) | 2.90174929 |
| 139 | cellular response to ethanol (GO:0071361) | 2.90064780 |
| 140 | striatum development (GO:0021756) | 2.88897050 |
| 141 | regulation of hypersensitivity (GO:0002883) | 2.86766947 |
| 142 | synaptic transmission (GO:0007268) | 2.86567408 |
| 143 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.84724125 |
| 144 | detection of calcium ion (GO:0005513) | 2.84405183 |
| 145 | negative regulation of microtubule polymerization (GO:0031115) | 2.83311046 |
| 146 | response to cocaine (GO:0042220) | 2.83164696 |
| 147 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.83135963 |
| 148 | synapse assembly (GO:0007416) | 2.82877613 |
| 149 | cytokine secretion (GO:0050663) | 2.82405698 |
| 150 | regulation of catecholamine metabolic process (GO:0042069) | 2.81981234 |
| 151 | regulation of dopamine metabolic process (GO:0042053) | 2.81981234 |
| 152 | social behavior (GO:0035176) | 2.81897283 |
| 153 | intraspecies interaction between organisms (GO:0051703) | 2.81897283 |
| 154 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80767287 |
| 155 | T-helper 1 type immune response (GO:0042088) | 2.80002377 |
| 156 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.78745591 |
| 157 | auditory behavior (GO:0031223) | 2.78191444 |
| 158 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.77468939 |
| 159 | learning (GO:0007612) | 2.76961427 |
| 160 | hydrogen ion transmembrane transport (GO:1902600) | 2.76214545 |
| 161 | phagosome maturation (GO:0090382) | 2.76000380 |
| 162 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75832637 |
| 163 | regulation of mononuclear cell migration (GO:0071675) | 2.75240227 |
| 164 | membrane hyperpolarization (GO:0060081) | 2.74867290 |
| 165 | negative regulation of interleukin-10 production (GO:0032693) | 2.74326309 |
| 166 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73521190 |
| 167 | negative regulation of DNA recombination (GO:0045910) | 2.73035587 |
| 168 | response to host (GO:0075136) | 2.70422350 |
| 169 | response to host defenses (GO:0052200) | 2.70422350 |
| 170 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70422350 |
| 171 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70241369 |
| 172 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.69254199 |
| 173 | neutrophil chemotaxis (GO:0030593) | 2.68784631 |
| 174 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68504159 |
| 175 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67649020 |
| 176 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.66362993 |
| 177 | proteasome assembly (GO:0043248) | 2.66175290 |
| 178 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64764524 |
| 179 | mitotic G2/M transition checkpoint (GO:0044818) | 2.64251222 |
| 180 | glycolipid catabolic process (GO:0019377) | 2.63389629 |
| 181 | myeloid leukocyte activation (GO:0002274) | 2.62487095 |
| 182 | retinal cone cell development (GO:0046549) | 2.62065995 |
| 183 | neutrophil migration (GO:1990266) | 2.61559577 |
| 184 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58052114 |
| 185 | membrane invagination (GO:0010324) | 2.57816094 |
| 186 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.56330547 |
| 187 | DNA strand elongation (GO:0022616) | 2.56153696 |
| 188 | regulation of exit from mitosis (GO:0007096) | 2.56141476 |
| 189 | N-terminal protein amino acid acetylation (GO:0006474) | 2.55631902 |
| 190 | I-kappaB phosphorylation (GO:0007252) | 2.55412691 |
| 191 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.54641268 |
| 192 | purine-containing compound salvage (GO:0043101) | 2.54258289 |
| 193 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.53773340 |
| 194 | chromatin remodeling at centromere (GO:0031055) | 2.52476946 |
| 195 | regulation of leukocyte degranulation (GO:0043300) | 2.52469891 |
| 196 | CENP-A containing nucleosome assembly (GO:0034080) | 2.50437870 |
| 197 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.49925842 |
| 198 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.48126969 |
| 199 | negative regulation of interleukin-1 production (GO:0032692) | 2.47411285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.03235295 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.99919559 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.47637962 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.28162490 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.43470281 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.41823585 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38408116 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.22317145 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.13723347 |
| 10 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 3.13359024 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.10570216 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.97611414 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.89045433 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.87222201 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.85878405 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.85620141 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.84486601 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80696976 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80696976 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.79228570 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72243537 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.66680937 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65943116 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56692583 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.56307746 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.53253939 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47704243 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39274342 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36871227 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.35196639 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33149870 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 2.32361664 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.32311674 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31147539 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.29943950 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.24786768 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22760264 |
| 38 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18610674 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17641653 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15250499 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13985408 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13243629 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12649795 |
| 44 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08688307 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07794496 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06754279 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03846427 |
| 48 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.03600433 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95004948 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94364712 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91485890 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89759184 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89405065 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.87138133 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.82308851 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.82097998 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82039188 |
| 58 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80162721 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72260892 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71343473 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69500416 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.68630494 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68536625 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67406938 |
| 65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.65409587 |
| 66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.64967261 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64134091 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63836298 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.63350581 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60579939 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58990093 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57783578 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55661014 |
| 74 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54530894 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54147154 |
| 76 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53369712 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51043384 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50232369 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49420524 |
| 80 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.47907331 |
| 81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46926305 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44264603 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41501961 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39920286 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37358054 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36890702 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36066711 |
| 88 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36051281 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35570441 |
| 90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35445672 |
| 91 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35440494 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35426621 |
| 93 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33832548 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31967700 |
| 95 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31368523 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31168668 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29490656 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28421143 |
| 99 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26008927 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25957879 |
| 101 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25806011 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25338790 |
| 103 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23611611 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23289221 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23153318 |
| 106 | * JUN_21703547_ChIP-Seq_K562_Human | 1.21583087 |
| 107 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21299915 |
| 108 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19912492 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19456094 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16792525 |
| 111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16547264 |
| 112 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16547264 |
| 113 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15102207 |
| 114 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15004007 |
| 115 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14613274 |
| 116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12484166 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 1.12051104 |
| 118 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11635268 |
| 119 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11142016 |
| 120 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10800771 |
| 121 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08701616 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08111287 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07405553 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05582944 |
| 125 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.04891674 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04369099 |
| 127 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02585750 |
| 128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01330238 |
| 129 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00200336 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00143531 |
| 131 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98289516 |
| 132 | MYB_26560356_Chip-Seq_TH1_Human | 0.97952842 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97764954 |
| 134 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97182797 |
| 135 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.96256747 |
| 136 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95791219 |
| 137 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95702824 |
| 138 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95400246 |
| 139 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95205639 |
| 140 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94754165 |
| 141 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.94649587 |
| 142 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.94649587 |
| 143 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.94649587 |
| 144 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94616684 |
| 145 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94448778 |
| 146 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94298800 |
| 147 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94261397 |
| 148 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94151105 |
| 149 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93693056 |
| 150 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93492437 |
| 151 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93300361 |
| 152 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93089778 |
| 153 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92039872 |
| 154 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91975282 |
| 155 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91657655 |
| 156 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.91204304 |
| 157 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90824972 |
| 158 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90528431 |
| 159 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.89962808 |
| 160 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89715593 |
| 161 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89713595 |
| 162 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89713595 |
| 163 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88803064 |
| 164 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88726753 |
| 165 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88396795 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87314782 |
| 167 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86984257 |
| 168 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86868444 |
| 169 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86659419 |
| 170 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86612954 |
| 171 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86481385 |
| 172 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86208735 |
| 173 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.85365825 |
| 174 | EWS_26573619_Chip-Seq_HEK293_Human | 0.84446175 |
| 175 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83485534 |
| 176 | AR_19668381_ChIP-Seq_PC3_Human | 0.82773770 |
| 177 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.80867941 |
| 178 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78534709 |
| 179 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77597448 |
| 180 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76516044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.67761912 |
| 2 | MP0003880_abnormal_central_pattern | 4.61845291 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.89212341 |
| 4 | MP0002876_abnormal_thyroid_physiology | 3.68855734 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.52376443 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.47944157 |
| 7 | MP0009046_muscle_twitch | 3.39330038 |
| 8 | MP0009745_abnormal_behavioral_response | 3.33534413 |
| 9 | MP0002064_seizures | 3.14614182 |
| 10 | MP0001501_abnormal_sleep_pattern | 2.98948543 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.96336088 |
| 12 | MP0005671_abnormal_response_to | 2.91381808 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.86159366 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.73572243 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.73473266 |
| 16 | MP0009840_abnormal_foam_cell | 2.72752238 |
| 17 | MP0003724_increased_susceptibility_to | 2.68074428 |
| 18 | MP0003303_peritoneal_inflammation | 2.67569063 |
| 19 | MP0002272_abnormal_nervous_system | 2.66541975 |
| 20 | MP0003436_decreased_susceptibility_to | 2.52884098 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.51932005 |
| 22 | MP0002419_abnormal_innate_immunity | 2.50744396 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.49951301 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.45520725 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.42133174 |
| 26 | MP0008877_abnormal_DNA_methylation | 2.41274207 |
| 27 | MP0001529_abnormal_vocalization | 2.40908068 |
| 28 | MP0002254_reproductive_system_inflammat | 2.34614300 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.32624403 |
| 30 | MP0009785_altered_susceptibility_to | 2.28030882 |
| 31 | MP0004270_analgesia | 2.27635338 |
| 32 | MP0001905_abnormal_dopamine_level | 2.23167015 |
| 33 | MP0001486_abnormal_startle_reflex | 2.17983868 |
| 34 | MP0002822_catalepsy | 2.11020161 |
| 35 | MP0002736_abnormal_nociception_after | 2.09253507 |
| 36 | MP0006082_CNS_inflammation | 2.07888082 |
| 37 | MP0005025_abnormal_response_to | 2.07561812 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 2.07392789 |
| 39 | MP0005423_abnormal_somatic_nervous | 2.01638413 |
| 40 | MP0001970_abnormal_pain_threshold | 2.01166251 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.97159135 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.96272446 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.95928875 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.94686268 |
| 45 | MP0001790_abnormal_immune_system | 1.92438986 |
| 46 | MP0005387_immune_system_phenotype | 1.92438986 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.86594908 |
| 48 | MP0001800_abnormal_humoral_immune | 1.86539552 |
| 49 | MP0003879_abnormal_hair_cell | 1.86234776 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.85936560 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.85762880 |
| 52 | MP0002184_abnormal_innervation | 1.82435070 |
| 53 | MP0002723_abnormal_immune_serum | 1.79449981 |
| 54 | MP0009764_decreased_sensitivity_to | 1.79293388 |
| 55 | MP0008260_abnormal_autophagy | 1.75494399 |
| 56 | MP0003122_maternal_imprinting | 1.73806076 |
| 57 | MP0001819_abnormal_immune_cell | 1.73569128 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.73531411 |
| 59 | MP0000778_abnormal_nervous_system | 1.71097298 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.68212964 |
| 61 | MP0008872_abnormal_physiological_respon | 1.66589620 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.65188509 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.64602928 |
| 64 | MP0004142_abnormal_muscle_tone | 1.64499640 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.62307798 |
| 66 | MP0009278_abnormal_bone_marrow | 1.61240172 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.60215889 |
| 68 | MP0000604_amyloidosis | 1.59374729 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.54859448 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.54714110 |
| 71 | MP0003690_abnormal_glial_cell | 1.53522006 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.51993370 |
| 73 | MP0003011_delayed_dark_adaptation | 1.51971067 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.51405916 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.46842832 |
| 76 | MP0004924_abnormal_behavior | 1.46842832 |
| 77 | MP0004742_abnormal_vestibular_system | 1.45282726 |
| 78 | MP0001188_hyperpigmentation | 1.44799516 |
| 79 | MP0002405_respiratory_system_inflammati | 1.38721512 |
| 80 | MP0008569_lethality_at_weaning | 1.38240979 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.36937478 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 1.34002208 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 1.31203117 |
| 84 | MP0002009_preneoplasia | 1.30530327 |
| 85 | MP0006292_abnormal_olfactory_placode | 1.29589824 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.28379773 |
| 87 | MP0000751_myopathy | 1.27142750 |
| 88 | MP0005535_abnormal_body_temperature | 1.25278781 |
| 89 | MP0003075_altered_response_to | 1.24913737 |
| 90 | MP0001502_abnormal_circadian_rhythm | 1.24634984 |
| 91 | MP0000538_abnormal_urinary_bladder | 1.24047762 |
| 92 | MP0003329_amyloid_beta_deposits | 1.23346863 |
| 93 | MP0004811_abnormal_neuron_physiology | 1.22692691 |
| 94 | MP0010307_abnormal_tumor_latency | 1.21976080 |
| 95 | MP0001845_abnormal_inflammatory_respons | 1.21219226 |
| 96 | MP0000716_abnormal_immune_system | 1.20737983 |
| 97 | MP0000920_abnormal_myelination | 1.19977285 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 1.19957976 |
| 99 | MP0008058_abnormal_DNA_repair | 1.19811138 |
| 100 | MP0002882_abnormal_neuron_morphology | 1.18415185 |
| 101 | MP0001984_abnormal_olfaction | 1.18412427 |
| 102 | MP0008874_decreased_physiological_sensi | 1.18002467 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 1.16879525 |
| 104 | MP0001533_abnormal_skeleton_physiology | 1.14889245 |
| 105 | MP0002398_abnormal_bone_marrow | 1.14222949 |
| 106 | MP0003195_calcinosis | 1.13537297 |
| 107 | MP0001853_heart_inflammation | 1.09673597 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 1.07275890 |
| 109 | MP0005310_abnormal_salivary_gland | 1.06360502 |
| 110 | MP0000689_abnormal_spleen_morphology | 1.06038550 |
| 111 | MP0000955_abnormal_spinal_cord | 1.05751871 |
| 112 | MP0003828_pulmonary_edema | 1.04026982 |
| 113 | MP0001963_abnormal_hearing_physiology | 1.03968973 |
| 114 | MP0003787_abnormal_imprinting | 1.02568685 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 1.00819409 |
| 116 | MP0008469_abnormal_protein_level | 1.00802553 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.99279739 |
| 118 | MP0001664_abnormal_digestion | 0.97721466 |
| 119 | MP0002102_abnormal_ear_morphology | 0.95245404 |
| 120 | MP0003448_altered_tumor_morphology | 0.94200652 |
| 121 | MP0000343_altered_response_to | 0.94026365 |
| 122 | MP0004510_myositis | 0.93945947 |
| 123 | MP0008057_abnormal_DNA_replication | 0.93761546 |
| 124 | MP0006072_abnormal_retinal_apoptosis | 0.92855260 |
| 125 | MP0004885_abnormal_endolymph | 0.92234056 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.91289400 |
| 127 | MP0004883_abnormal_blood_vessel | 0.90278574 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.89650459 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.88752789 |
| 130 | MP0002429_abnormal_blood_cell | 0.88393174 |
| 131 | MP0002229_neurodegeneration | 0.88346925 |
| 132 | MP0002722_abnormal_immune_system | 0.86907734 |
| 133 | MP0003866_abnormal_defecation | 0.84459871 |
| 134 | MP0002152_abnormal_brain_morphology | 0.83898652 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.83734206 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.81732748 |
| 137 | MP0002752_abnormal_somatic_nervous | 0.81701018 |
| 138 | MP0000685_abnormal_immune_system | 0.80780057 |
| 139 | MP0000631_abnormal_neuroendocrine_gland | 0.80748360 |
| 140 | MP0009379_abnormal_foot_pigmentation | 0.80127433 |
| 141 | MP0005551_abnormal_eye_electrophysiolog | 0.79310767 |
| 142 | MP0000026_abnormal_inner_ear | 0.78469560 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.78031560 |
| 144 | MP0003959_abnormal_lean_body | 0.77730624 |
| 145 | MP0003111_abnormal_nucleus_morphology | 0.77667632 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.76015298 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.75857130 |
| 148 | MP0002132_abnormal_respiratory_system | 0.75683218 |
| 149 | MP0009763_increased_sensitivity_to | 0.74556575 |
| 150 | MP0001485_abnormal_pinna_reflex | 0.73994639 |
| 151 | MP0001177_atelectasis | 0.73913158 |
| 152 | MP0002090_abnormal_vision | 0.71788086 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.70824240 |
| 154 | MP0005397_hematopoietic_system_phenotyp | 0.70824240 |
| 155 | MP0002095_abnormal_skin_pigmentation | 0.70734586 |
| 156 | MP0005394_taste/olfaction_phenotype | 0.68877302 |
| 157 | MP0005499_abnormal_olfactory_system | 0.68877302 |
| 158 | MP0003693_abnormal_embryo_hatching | 0.67371537 |
| 159 | MP0004085_abnormal_heartbeat | 0.65356731 |
| 160 | MP0003631_nervous_system_phenotype | 0.63194576 |
| 161 | MP0004043_abnormal_pH_regulation | 0.62061406 |
| 162 | MP0001943_abnormal_respiration | 0.61774527 |
| 163 | MP0003633_abnormal_nervous_system | 0.61607065 |
| 164 | MP0003938_abnormal_ear_development | 0.59952658 |
| 165 | MP0004484_altered_response_of | 0.58385601 |
| 166 | MP0009780_abnormal_chondrocyte_physiolo | 0.57007689 |
| 167 | MP0000462_abnormal_digestive_system | 0.56857999 |
| 168 | MP0002163_abnormal_gland_morphology | 0.56053843 |
| 169 | MP0004215_abnormal_myocardial_fiber | 0.55558316 |
| 170 | MP0003121_genomic_imprinting | 0.48920381 |
| 171 | MP0000747_muscle_weakness | 0.48714545 |
| 172 | MP0000681_abnormal_thyroid_gland | 0.48457409 |
| 173 | MP0004858_abnormal_nervous_system | 0.48210183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.92480084 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.89090388 |
| 3 | Atonic seizures (HP:0010819) | 4.76553883 |
| 4 | Focal seizures (HP:0007359) | 4.69714861 |
| 5 | Myokymia (HP:0002411) | 4.50427016 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.48405332 |
| 7 | Limb dystonia (HP:0002451) | 4.32031591 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.26530829 |
| 9 | Absence seizures (HP:0002121) | 4.22376443 |
| 10 | Visual hallucinations (HP:0002367) | 4.00982475 |
| 11 | Hyperventilation (HP:0002883) | 3.98818387 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.90211577 |
| 13 | Optic neuritis (HP:0100653) | 3.90211577 |
| 14 | Febrile seizures (HP:0002373) | 3.86102451 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.82580526 |
| 16 | Stomatitis (HP:0010280) | 3.80774707 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.79062349 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.69157148 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.66670029 |
| 20 | Dialeptic seizures (HP:0011146) | 3.64828744 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 3.54498417 |
| 22 | Mutism (HP:0002300) | 3.51998596 |
| 23 | Poor suck (HP:0002033) | 3.46733219 |
| 24 | Orchitis (HP:0100796) | 3.42420287 |
| 25 | Agnosia (HP:0010524) | 3.39163138 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37944822 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.34697542 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.28542344 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.24264973 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.24264973 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.24264973 |
| 32 | Disinhibition (HP:0000734) | 3.21678528 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 3.21177430 |
| 34 | Pheochromocytoma (HP:0002666) | 3.15615686 |
| 35 | Myositis (HP:0100614) | 3.13142915 |
| 36 | Progressive macrocephaly (HP:0004481) | 3.11097189 |
| 37 | Gait imbalance (HP:0002141) | 3.07712340 |
| 38 | Mitochondrial inheritance (HP:0001427) | 3.07711657 |
| 39 | Polyphagia (HP:0002591) | 3.03685023 |
| 40 | Acute encephalopathy (HP:0006846) | 2.98166654 |
| 41 | Hypothermia (HP:0002045) | 2.95558814 |
| 42 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.90946389 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.86909807 |
| 44 | Increased circulating renin level (HP:0000848) | 2.86016206 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.79655596 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77032992 |
| 47 | Failure to thrive in infancy (HP:0001531) | 2.76936878 |
| 48 | Abnormal eating behavior (HP:0100738) | 2.76744148 |
| 49 | Recurrent skin infections (HP:0001581) | 2.75693193 |
| 50 | Progressive inability to walk (HP:0002505) | 2.75377531 |
| 51 | Abnormal pupillary function (HP:0007686) | 2.74135425 |
| 52 | Broad-based gait (HP:0002136) | 2.71884090 |
| 53 | Abnormality of chromosome stability (HP:0003220) | 2.70213820 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.67976361 |
| 55 | Peripheral hypomyelination (HP:0007182) | 2.62635134 |
| 56 | Increased CSF lactate (HP:0002490) | 2.62410633 |
| 57 | Premature ovarian failure (HP:0008209) | 2.58225395 |
| 58 | Loss of speech (HP:0002371) | 2.58126062 |
| 59 | Encephalitis (HP:0002383) | 2.56664283 |
| 60 | Reticulocytopenia (HP:0001896) | 2.55582933 |
| 61 | Anxiety (HP:0000739) | 2.54710839 |
| 62 | Vaginal atresia (HP:0000148) | 2.53617723 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.52033537 |
| 64 | Diplopia (HP:0000651) | 2.52033537 |
| 65 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.51418747 |
| 66 | Prostate neoplasm (HP:0100787) | 2.50263219 |
| 67 | Genital tract atresia (HP:0001827) | 2.49603990 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.49563637 |
| 69 | Nephrogenic diabetes insipidus (HP:0009806) | 2.49265714 |
| 70 | Glomerulonephritis (HP:0000099) | 2.48527373 |
| 71 | Medial flaring of the eyebrow (HP:0010747) | 2.48374514 |
| 72 | Hypoventilation (HP:0002791) | 2.47957010 |
| 73 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45780666 |
| 74 | Obstructive lung disease (HP:0006536) | 2.44012220 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44012220 |
| 76 | Meningitis (HP:0001287) | 2.43714755 |
| 77 | Confusion (HP:0001289) | 2.43702172 |
| 78 | Impaired social interactions (HP:0000735) | 2.41185228 |
| 79 | Abnormal social behavior (HP:0012433) | 2.41185228 |
| 80 | Amblyopia (HP:0000646) | 2.40058573 |
| 81 | Inability to walk (HP:0002540) | 2.39870478 |
| 82 | IgM deficiency (HP:0002850) | 2.37711054 |
| 83 | Memory impairment (HP:0002354) | 2.37428409 |
| 84 | Premature loss of primary teeth (HP:0006323) | 2.37373864 |
| 85 | Narrow nasal bridge (HP:0000446) | 2.37221159 |
| 86 | Recurrent fungal infections (HP:0002841) | 2.36743646 |
| 87 | Hyperthyroidism (HP:0000836) | 2.36392832 |
| 88 | Supranuclear gaze palsy (HP:0000605) | 2.33634435 |
| 89 | Retinal dysplasia (HP:0007973) | 2.32145522 |
| 90 | Exertional dyspnea (HP:0002875) | 2.29493720 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.27709848 |
| 92 | Meckel diverticulum (HP:0002245) | 2.25819197 |
| 93 | Gout (HP:0001997) | 2.23995949 |
| 94 | Hypomagnesemia (HP:0002917) | 2.23193640 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 2.22877157 |
| 96 | Excessive salivation (HP:0003781) | 2.22556231 |
| 97 | Drooling (HP:0002307) | 2.22556231 |
| 98 | Epileptiform EEG discharges (HP:0011182) | 2.20042171 |
| 99 | Autoimmune thrombocytopenia (HP:0001973) | 2.18880300 |
| 100 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.18219781 |
| 101 | T lymphocytopenia (HP:0005403) | 2.17829421 |
| 102 | Poor eye contact (HP:0000817) | 2.17335549 |
| 103 | Scanning speech (HP:0002168) | 2.16545028 |
| 104 | Increased hepatocellular lipid droplets (HP:0006565) | 2.15756506 |
| 105 | Vacuolated lymphocytes (HP:0001922) | 2.14670768 |
| 106 | Abnormality of the ileum (HP:0001549) | 2.12541676 |
| 107 | Hemoptysis (HP:0002105) | 2.12135330 |
| 108 | Colon cancer (HP:0003003) | 2.12100965 |
| 109 | Abnormal hair whorl (HP:0010721) | 2.12068382 |
| 110 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11434462 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 2.10067797 |
| 112 | Leukodystrophy (HP:0002415) | 2.09963207 |
| 113 | Renal Fanconi syndrome (HP:0001994) | 2.09804029 |
| 114 | Respiratory difficulties (HP:0002880) | 2.09682498 |
| 115 | Birth length less than 3rd percentile (HP:0003561) | 2.09490736 |
| 116 | Psychosis (HP:0000709) | 2.08944299 |
| 117 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.07856302 |
| 118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.07856302 |
| 119 | Pulmonary infiltrates (HP:0002113) | 2.07137167 |
| 120 | Optic disc pallor (HP:0000543) | 2.06550663 |
| 121 | Fetal akinesia sequence (HP:0001989) | 2.05922921 |
| 122 | Thickened helices (HP:0000391) | 2.05862419 |
| 123 | Status epilepticus (HP:0002133) | 2.04751515 |
| 124 | Hepatocellular necrosis (HP:0001404) | 2.04465573 |
| 125 | Asplenia (HP:0001746) | 2.03826879 |
| 126 | Inappropriate behavior (HP:0000719) | 2.02359468 |
| 127 | Papilledema (HP:0001085) | 2.01225520 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 1.99324304 |
| 129 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.99144458 |
| 130 | Abnormality of the preputium (HP:0100587) | 1.98304517 |
| 131 | Amyloidosis (HP:0011034) | 1.97881173 |
| 132 | Hypsarrhythmia (HP:0002521) | 1.97207274 |
| 133 | Tinnitus (HP:0000360) | 1.96756924 |
| 134 | Poor head control (HP:0002421) | 1.96020093 |
| 135 | Gingivitis (HP:0000230) | 1.95529556 |
| 136 | Episodic fever (HP:0001954) | 1.95176616 |
| 137 | Osteomyelitis (HP:0002754) | 1.94183421 |
| 138 | Hyperphosphaturia (HP:0003109) | 1.93240680 |
| 139 | Abnormality of the prostate (HP:0008775) | 1.92417599 |
| 140 | Shoulder girdle muscle weakness (HP:0003547) | 1.91628579 |
| 141 | Urticaria (HP:0001025) | 1.91445392 |
| 142 | Abnormality of renal resorption (HP:0011038) | 1.90666234 |
| 143 | Cerebral edema (HP:0002181) | 1.90033097 |
| 144 | Hypercortisolism (HP:0001578) | 1.89354653 |
| 145 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.88869465 |
| 146 | Specific learning disability (HP:0001328) | 1.88405272 |
| 147 | Recurrent viral infections (HP:0004429) | 1.88230203 |
| 148 | Metabolic alkalosis (HP:0200114) | 1.87812294 |
| 149 | Abnormality of the labia minora (HP:0012880) | 1.87017103 |
| 150 | Neurofibrillary tangles (HP:0002185) | 1.86287507 |
| 151 | Neurodegeneration (HP:0002180) | 1.86278199 |
| 152 | Blue irides (HP:0000635) | 1.84777428 |
| 153 | Absent speech (HP:0001344) | 1.84389514 |
| 154 | Truncal ataxia (HP:0002078) | 1.84348063 |
| 155 | Gastrointestinal infarctions (HP:0005244) | 1.84162101 |
| 156 | Abnormality of salivation (HP:0100755) | 1.83780195 |
| 157 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83614591 |
| 158 | Dysdiadochokinesis (HP:0002075) | 1.82698980 |
| 159 | Truncus arteriosus (HP:0001660) | 1.82286575 |
| 160 | Apathy (HP:0000741) | 1.81976435 |
| 161 | Abnormal ciliary motility (HP:0012262) | 1.81724631 |
| 162 | Poor coordination (HP:0002370) | 1.81573960 |
| 163 | Leukocytosis (HP:0001974) | 1.81502197 |
| 164 | Peripheral demyelination (HP:0011096) | 1.79574057 |
| 165 | Esotropia (HP:0000565) | 1.77345635 |
| 166 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.76775299 |
| 167 | Recurrent cutaneous fungal infections (HP:0011370) | 1.76775299 |
| 168 | Depression (HP:0000716) | 1.76575799 |
| 169 | Progressive external ophthalmoplegia (HP:0000590) | 1.76427436 |
| 170 | Ketoacidosis (HP:0001993) | 1.75737210 |
| 171 | Axonal loss (HP:0003447) | 1.75581061 |
| 172 | Absent/shortened dynein arms (HP:0200106) | 1.75084170 |
| 173 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75084170 |
| 174 | Vasculitis (HP:0002633) | 1.74995840 |
| 175 | Abnormality of T cell number (HP:0011839) | 1.74811487 |
| 176 | Decreased muscle mass (HP:0003199) | 1.74732550 |
| 177 | Urinary urgency (HP:0000012) | 1.74399242 |
| 178 | Lipid accumulation in hepatocytes (HP:0006561) | 1.73698376 |
| 179 | Vertigo (HP:0002321) | 1.73124869 |
| 180 | Dysphonia (HP:0001618) | 1.72853726 |
| 181 | Abnormal number of incisors (HP:0011064) | 1.72798675 |
| 182 | Medulloblastoma (HP:0002885) | 1.72549370 |
| 183 | Cortical visual impairment (HP:0100704) | 1.71405466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.35426084 |
| 2 | MAP3K4 | 4.57437966 |
| 3 | MAP3K12 | 4.20852932 |
| 4 | MAP2K7 | 4.13913413 |
| 5 | PNCK | 3.30191354 |
| 6 | NTRK3 | 3.20789931 |
| 7 | BLK | 2.95929842 |
| 8 | TNIK | 2.89086876 |
| 9 | MAP2K4 | 2.80102443 |
| 10 | MARK1 | 2.62020369 |
| 11 | CASK | 2.58851945 |
| 12 | DMPK | 2.52448938 |
| 13 | MINK1 | 2.49604928 |
| 14 | CDC7 | 2.37549230 |
| 15 | VRK2 | 2.35964602 |
| 16 | TAF1 | 2.29455558 |
| 17 | IRAK2 | 2.18246606 |
| 18 | TXK | 2.06849497 |
| 19 | MAP3K9 | 2.04078794 |
| 20 | MAPKAPK5 | 1.95460556 |
| 21 | OXSR1 | 1.94621518 |
| 22 | NME1 | 1.92211910 |
| 23 | WNK4 | 1.91567108 |
| 24 | GRK5 | 1.86749984 |
| 25 | EPHA4 | 1.85938554 |
| 26 | IRAK4 | 1.84446045 |
| 27 | NTRK2 | 1.83546126 |
| 28 | ZAK | 1.73933949 |
| 29 | TSSK6 | 1.66987368 |
| 30 | TYK2 | 1.63269944 |
| 31 | PLK2 | 1.60145994 |
| 32 | MAP3K11 | 1.57737645 |
| 33 | TRIM28 | 1.56003826 |
| 34 | CSK | 1.52595844 |
| 35 | ACVR1B | 1.49689840 |
| 36 | NTRK1 | 1.48816659 |
| 37 | SIK2 | 1.44333116 |
| 38 | GRK7 | 1.43835766 |
| 39 | MAPK13 | 1.42837069 |
| 40 | STK39 | 1.35700987 |
| 41 | WNK3 | 1.34284130 |
| 42 | VRK1 | 1.27779519 |
| 43 | FES | 1.26740994 |
| 44 | MAP4K1 | 1.25335859 |
| 45 | CSNK1G2 | 1.24992364 |
| 46 | CSNK1G3 | 1.20596821 |
| 47 | PRKCG | 1.19878752 |
| 48 | UHMK1 | 1.18537389 |
| 49 | CSF1R | 1.15267917 |
| 50 | IRAK1 | 1.14751825 |
| 51 | CAMK2B | 1.13994481 |
| 52 | CDK19 | 1.13817045 |
| 53 | RIPK4 | 1.13722238 |
| 54 | ADRBK2 | 1.13422370 |
| 55 | SCYL2 | 1.12535554 |
| 56 | BMPR2 | 1.11275233 |
| 57 | MAP3K6 | 1.11104414 |
| 58 | CAMK2A | 1.11047016 |
| 59 | DAPK1 | 1.10213937 |
| 60 | SIK3 | 1.07697639 |
| 61 | LYN | 1.06142504 |
| 62 | CDK5 | 1.05569991 |
| 63 | IKBKE | 1.04171348 |
| 64 | ARAF | 1.02872474 |
| 65 | NUAK1 | 1.00891609 |
| 66 | YES1 | 0.98306071 |
| 67 | CDK8 | 0.98168358 |
| 68 | MYLK | 0.94119121 |
| 69 | SRPK1 | 0.91806036 |
| 70 | JAK2 | 0.90655955 |
| 71 | CDK14 | 0.86161116 |
| 72 | BCR | 0.85987736 |
| 73 | CAMK2G | 0.85232011 |
| 74 | PAK6 | 0.84812429 |
| 75 | GRK6 | 0.84623853 |
| 76 | MST4 | 0.84547192 |
| 77 | STK16 | 0.83386502 |
| 78 | HCK | 0.82200673 |
| 79 | ADRBK1 | 0.79891681 |
| 80 | DYRK1A | 0.78840654 |
| 81 | KSR1 | 0.78751661 |
| 82 | BUB1 | 0.77780773 |
| 83 | TYRO3 | 0.76449364 |
| 84 | CDK18 | 0.76338909 |
| 85 | CDK15 | 0.73911320 |
| 86 | MAP3K13 | 0.73534048 |
| 87 | PRKCE | 0.73110311 |
| 88 | CDK3 | 0.72272881 |
| 89 | CAMK2D | 0.71672818 |
| 90 | FGR | 0.67366019 |
| 91 | TLK1 | 0.66675648 |
| 92 | ZAP70 | 0.65064775 |
| 93 | TEC | 0.65045513 |
| 94 | NLK | 0.64134330 |
| 95 | CAMK1D | 0.63936582 |
| 96 | IKBKB | 0.63530822 |
| 97 | TTK | 0.63347304 |
| 98 | CSNK1G1 | 0.62993634 |
| 99 | DAPK2 | 0.62958576 |
| 100 | FYN | 0.62208507 |
| 101 | CAMK1G | 0.60788010 |
| 102 | CDK9 | 0.60756867 |
| 103 | CAMKK2 | 0.60126216 |
| 104 | INSRR | 0.59683675 |
| 105 | CDK11A | 0.58736040 |
| 106 | RET | 0.58109940 |
| 107 | NEK6 | 0.57908271 |
| 108 | PDK1 | 0.56882847 |
| 109 | BTK | 0.56702107 |
| 110 | TGFBR2 | 0.55217141 |
| 111 | ALK | 0.54547253 |
| 112 | LCK | 0.54255692 |
| 113 | JAK3 | 0.53773365 |
| 114 | MAP2K3 | 0.53694076 |
| 115 | MELK | 0.52017710 |
| 116 | CDK6 | 0.51974246 |
| 117 | STK24 | 0.50698769 |
| 118 | JAK1 | 0.49838279 |
| 119 | BMPR1B | 0.49502419 |
| 120 | ERBB4 | 0.49303202 |
| 121 | TNK2 | 0.49176349 |
| 122 | PHKG2 | 0.47652439 |
| 123 | PHKG1 | 0.47652439 |
| 124 | PAK3 | 0.47362052 |
| 125 | TESK2 | 0.47000262 |
| 126 | SGK494 | 0.45898920 |
| 127 | SGK223 | 0.45898920 |
| 128 | ATR | 0.45877085 |
| 129 | LATS2 | 0.45726552 |
| 130 | ROCK2 | 0.45454394 |
| 131 | MATK | 0.44734688 |
| 132 | KSR2 | 0.41204982 |
| 133 | PRKACA | 0.40733971 |
| 134 | FER | 0.40423866 |
| 135 | PRKG1 | 0.39360037 |
| 136 | ERBB3 | 0.39003591 |
| 137 | CAMK1 | 0.38779193 |
| 138 | PDK3 | 0.37529229 |
| 139 | PDK4 | 0.37529229 |
| 140 | MAP3K14 | 0.37469360 |
| 141 | CHEK2 | 0.37047000 |
| 142 | MKNK2 | 0.35783341 |
| 143 | PBK | 0.35552521 |
| 144 | PRKACB | 0.35343321 |
| 145 | MAP3K5 | 0.35323528 |
| 146 | PLK4 | 0.35307486 |
| 147 | CSNK2A1 | 0.35274101 |
| 148 | PIM1 | 0.34932592 |
| 149 | PRKCZ | 0.34882575 |
| 150 | RPS6KA5 | 0.34554636 |
| 151 | MAPK12 | 0.33728077 |
| 152 | CSNK1A1L | 0.33413019 |
| 153 | STK11 | 0.33154791 |
| 154 | SGK1 | 0.30414625 |
| 155 | SYK | 0.30212294 |
| 156 | PKN1 | 0.28826142 |
| 157 | CAMKK1 | 0.28436392 |
| 158 | MARK2 | 0.28150110 |
| 159 | PTK2B | 0.27615102 |
| 160 | PRKCB | 0.25869687 |
| 161 | PRKCA | 0.25316555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.27204896 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.17500600 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.69536938 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.60951382 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.48949139 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96201171 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.81806867 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.78656248 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59692805 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.58513879 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.49323932 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41416627 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.27145931 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.23547817 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.23079675 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22623654 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.22304346 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20095984 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12884852 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.08757815 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 2.08413437 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 2.06340961 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05096349 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 2.02460759 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02443887 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.99356329 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.95966390 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95840091 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.94470418 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90344216 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.87948781 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87687349 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86170729 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85851638 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83827516 |
| 36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81831761 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.80800992 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.80798342 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.73934989 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.69157468 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68397261 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.67993886 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.65649446 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58832331 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54281568 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54129423 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.52413467 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.45462401 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44371764 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33830407 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31938614 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.31825430 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31487375 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.29776542 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28541190 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25481810 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25185872 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24980705 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.22492206 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 1.22455207 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21294298 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 1.19627450 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17198950 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 1.15317298 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10635254 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10202382 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09490318 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09112722 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06626536 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03726007 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02354637 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00375655 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97167790 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97138547 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.94065833 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93724987 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91117051 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89789704 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.86820688 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85816468 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.85781160 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85395664 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85031652 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81789222 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80635525 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.80574704 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80510024 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80459949 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80350845 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80313946 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80289171 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.79897540 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78395708 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78189061 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77785539 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.77675621 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.76576739 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.74284634 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.73223533 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72294721 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70751399 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70675007 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69740935 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68458292 |
| 105 | Cell cycle_Homo sapiens_hsa04110 | 0.64365175 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.62776709 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60473569 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59511124 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59284348 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57311024 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.55696030 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54761072 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.54647553 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54634930 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.53281241 |
| 116 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53216300 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52095573 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.52048410 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49941128 |
| 120 | RNA transport_Homo sapiens_hsa03013 | 0.49741075 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49514015 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48116623 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48115273 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46728863 |
| 125 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42650114 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41839764 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41618140 |
| 128 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39868557 |
| 129 | Proteasome_Homo sapiens_hsa03050 | 0.39009190 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.37115321 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36441621 |
| 132 | RNA degradation_Homo sapiens_hsa03018 | 0.35401305 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35326007 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33959922 |
| 135 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33013575 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.32616187 |
| 137 | Apoptosis_Homo sapiens_hsa04210 | 0.32585580 |
| 138 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31530714 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31309841 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31148675 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.30921706 |
| 142 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30758312 |
| 143 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30383089 |
| 144 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30127042 |
| 145 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29176808 |
| 146 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29092464 |
| 147 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28072470 |
| 148 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27761965 |
| 149 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26990512 |
| 150 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26340536 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26327694 |
| 152 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23126845 |
| 153 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20885705 |
| 154 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20710671 |
| 155 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20292228 |
| 156 | Glioma_Homo sapiens_hsa05214 | 0.19724943 |
| 157 | Bile secretion_Homo sapiens_hsa04976 | 0.18625941 |
| 158 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17122607 |
| 159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17037974 |
| 160 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.16426997 |
| 161 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.15287459 |
| 162 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14684772 |
| 163 | Carbon metabolism_Homo sapiens_hsa01200 | 0.14243360 |
| 164 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14173987 |
| 165 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.13196272 |

